Kuan Hu Selected Research

Substance-Related Disorders (Drug Abuse)

1/2020	Synthesis and preliminary studies of 11C-labeled tetrahydro-1,7-naphthyridine-2-carboxamides for PET imaging of metabotropic glutamate receptor 2.
10/2019	Design, Synthesis, and Evaluation of 18F-Labeled Monoacylglycerol Lipase Inhibitors as Novel Positron Emission Tomography Probes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kuan Hu Research Topics

Disease

43	Neoplasms (Cancer) 02/2024 - 04/2016
14	Hepatocellular Carcinoma (Hepatoma) 12/2023 - 12/2014
9	Neoplasm Metastasis (Metastasis) 01/2023 - 12/2014
6	Infections 05/2022 - 04/2015
4	Breast Neoplasms (Breast Cancer) 10/2023 - 11/2017
3	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2024 - 01/2019
3	Carcinogenesis 12/2023 - 01/2021
3	Liver Neoplasms (Liver Cancer) 10/2023 - 12/2014
3	Carcinoma (Carcinomatosis) 01/2022 - 02/2020
3	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2017
3	Cholangiocarcinoma 01/2021 - 03/2020
3	Hypoxia (Hypoxemia) 12/2020 - 11/2016
2	Parkinson Disease (Parkinson's Disease) 02/2024 - 01/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2022 - 01/2022
2	Inflammation (Inflammations) 01/2022 - 10/2020
2	Melanoma (Melanoma, Malignant) 01/2021 - 01/2020
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 01/2017
2	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 01/2019
2	Substance-Related Disorders (Drug Abuse) 01/2020 - 10/2019
2	Schizophrenia (Dementia Praecox) 01/2020 - 01/2019
2	Brain Diseases (Brain Disorder) 01/2020 - 05/2019
2	Liver Diseases (Liver Disease) 12/2019 - 05/2019
2	Teratocarcinoma 07/2017 - 01/2017
2	Tuberculosis (Tuberculoses) 01/2017 - 04/2015
1	Chronic Disease (Chronic Diseases) 01/2024
1	Communicable Diseases (Infectious Diseases) 01/2023
1	Glioblastoma (Glioblastoma Multiforme) 12/2022
1	Prostatic Neoplasms (Prostate Cancer) 11/2022
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 11/2022
1	Central Nervous System Diseases (CNS Diseases) 01/2022
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2022
1	Paraganglioma (Paragangliomas) 01/2022
1	Pheochromocytoma 01/2022
1	Squamous Cell Carcinoma of Head and Neck 01/2022

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 10/2023 - 04/2015
11	Biomarkers (Surrogate Marker)IBA 02/2024 - 04/2018
9	Peptides (Polypeptides)IBA 02/2024 - 01/2017
5	RadiopharmaceuticalsIBA 02/2024 - 01/2020
4	Proteasome Endopeptidase Complex (Proteasome)IBA 07/2017 - 04/2015
3	LigandsIBA 02/2024 - 01/2019
3	Radioisotopes (Radionuclides)IBA 11/2022 - 01/2020
3	PolymersIBA 06/2022 - 07/2017
3	Small Interfering RNA (siRNA)IBA 08/2019 - 01/2017
2	AntibodiesIBA 02/2024 - 01/2021
2	Phosphotransferases (Kinase)IBA 02/2024 - 01/2022
2	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 01/2020
2	Ubiquitin-Specific ProteasesIBA 11/2023 - 08/2023
2	EnzymesIBA 11/2023 - 01/2022
2	Tumor Biomarkers (Tumor Markers)IBA 01/2023 - 01/2021
2	Immune Checkpoint InhibitorsIBA 01/2023 - 06/2022
2	metabotropic glutamate receptor type 1IBA 01/2023 - 01/2020
2	Oncogene Proteins (Oncogene Protein)IBA 01/2023 - 01/2020
2	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2023 - 01/2020
2	Temozolomide (Temodar)FDA LinkGeneric 12/2022 - 01/2021
2	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2017
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022 - 01/2020
2	Sorafenib (BAY 43-9006)FDA Link 01/2021 - 01/2019
2	camrelizumabIBA 01/2021 - 10/2019
2	Phosphorus (Red Phosphorus)IBA 01/2020 - 07/2017
1	Leucine (L-Leucine)FDA Link 02/2024
1	CarbonIBA 01/2024
1	CateninsIBA 12/2023
1	Phosphatidylinositols (Phosphatidylinositol)IBA 11/2023
1	Phospholipid Transfer ProteinsIBA 11/2023
1	Protein Isoforms (Isoforms)IBA 11/2023
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 10/2023
1	A-Form DNA (A-DNA)IBA 08/2023
1	Fetal Proteins (Fetoprotein)IBA 01/2023
1	peptide AIBA 01/2023
1	Immune Checkpoint ProteinsIBA 01/2023
1	B7-H1 AntigenIBA 01/2023
1	Programmed Cell Death 1 ReceptorIBA 01/2023
1	Sodium IodideIBA 11/2022
1	OligonucleotidesIBA 10/2022
1	AGRO 100IBA 10/2022
1	Nucleic AcidsIBA 10/2022
1	ErbB Receptors (EGF Receptor)IBA 07/2022
1	Tyrosine Kinase InhibitorsIBA 07/2022
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 07/2022
1	Polyvinyl AlcoholIBA 06/2022
1	HydrogelsIBA 06/2022
1	PolyethyleneimineIBA 06/2022
1	MagnesiumIBA 06/2022
1	PolyaminesIBA 06/2022
1	Dexmedetomidine FDA Link 01/2022
1	Aminocaproic Acid (6 Aminocaproic Acid)FDA LinkGeneric 01/2022
1	4-carboxyphenylglyoxalIBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	pralsetinibIBA 01/2022
1	selpercatinibIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022

Therapy/Procedure

23	Therapeutics 02/2024 - 01/2017
3	Drug Therapy (Chemotherapy) 01/2021 - 01/2019
2	Precision Medicine 11/2022 - 01/2021
2	Immunomodulation 06/2022 - 01/2021
2	Immunotherapy 01/2022 - 01/2021
2	Radiotherapy 01/2021 - 12/2020
2	Hepatectomy 12/2019 - 01/2019
1	Electrodes (Electrode) 01/2024
1	Traction 01/2023